1. Home
  2. OPRT vs CCCC Comparison

OPRT vs CCCC Comparison

Compare OPRT & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oportun Financial Corporation

OPRT

Oportun Financial Corporation

SELL

Current Price

$8.78

Market Cap

378.5M

Sector

Finance

ML Signal

SELL

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

SELL

Current Price

$2.62

Market Cap

350.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
OPRT
CCCC
Founded
2005
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
378.5M
350.6M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
OPRT
CCCC
Price
$8.78
$2.62
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$11.50
★ $12.86
AVG Volume (30 Days)
721.8K
★ 2.1M
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 127.18
16.45
EPS
★ 0.22
N/A
Revenue
★ $956,685,000.00
$35,947,000.00
Revenue This Year
$30.33
N/A
Revenue Next Year
$5.23
N/A
P/E Ratio
$41.68
★ N/A
Revenue Growth
N/A
★ 1.02
52 Week Low
$4.03
$1.69
52 Week High
$9.27
$5.17

Technical Indicators

Market Signals
Indicator
OPRT
CCCC
Relative Strength Index (RSI) 60.05 33.80
Support Level $7.99 $2.52
Resistance Level N/A $3.91
Average True Range (ATR) 0.34 0.21
MACD 0.03 -0.01
Stochastic Oscillator 59.53 0.68

Price Performance

Historical Comparison
OPRT
CCCC

About OPRT Oportun Financial Corporation

Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: